Centrus reports Q4 EPS $3.20, two estimates $1.64

Reports Q4 revenue $151.6M, consensus $106.67M. “This was another strong quarter and year for Centrus as we expanded our backlog, demonstrated the success of our technology by continuing first-of-a-kind HALEU production, and restarted centrifuge manufacturing activities,” said Centrus President and CEO Amir Vexler. “At the same time, we secured new government contracts, made contingent sales of approximately $2.0 billion in contracts and commitments, and obtained private financing that will help underpin a potential expansion of our enrichment plant in Ohio. As the only U.S.-owned, U.S.-technology enrichment company, we are well-positioned to compete for more than $3.4 billion in federal funding that has been approved by Congress and uniquely positioned to deliver a made-in-America solution that supports American jobs.”